You just read:

Rewind Therapeutics Awarded €2.9 Million VLAIO Grant to Discover and Develop Novel Drug Candidates for Myelin-related Neurological Diseases

News provided by

Rewind Therapeutics

Aug 01, 2019, 03:05 ET